Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004-2005

Journal of Hospital Infection

Volumn 77, Issue 1, 2011, Pages 16-20

  Lamagni, T L ^a   Potz, N ^a   Powell, D ^a   Pebody, R ^a   Wilson, J ^a   Duckworth, G ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

England; Meticillin resistant Staphylococcus aureus; Mortality; Population surveillance

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; BLOOD SAMPLING; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; PATIENT IDENTIFICATION; POPULATION BASED CASE CONTROL STUDY; REGISTER; SEASONAL VARIATION; SEX DIFFERENCE; STANDARDIZED MORTALITY RATIO; SUMMER; UNITED KINGDOM; WINTER;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BACTEREMIA; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RISK FACTORS; SEASONS; SEX FACTORS; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 78650517550     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.07.015     Document Type: Article

References (22)

1. Swift B., West K. Death certification: an audit of practice entering the 21st century. J Clin Pathol 2002, 55:275-279.
2. Health Protection Agency National confidential study of deaths following meticillin resistant Staphylococcus aureus (MRSA) infection 2007, HPA, London.
3. Health Protection Agency New initiative to link surveillance and mortality data. Commun Dis Rep CDR Wkly [serial online] 2005, 15(38). News.
4. Health Protection Agency Surveillance of healthcare associated infections report: 2008 2008, HPA, London.
5. Potz N, Powell D, Lamagni TL, Pebody R, Bridger D, Duckworth G. Probabilistic record registrations: a tool to strengthen surveillance. Stat Commun Infect Dis (in press).
6. Seagroatt V., Goldacre M. Measures of early postoperative mortality: beyond hospital fatality rates. BMJ 1994, 309(6951):361-365.
7. Kirkwood B.R., Sterne J.A.C. Standardization. Medical statistics 2003, Blackwell, Oxford, pp. 263-271.
8. Turnidge J.D., Nimmo G.R., Pearson J., Gottlieb T., Collignon P.J. Epidemiology and outcomes for Staphylococcus aureus bacteraemia in Australian hospitals, 2005-06: report from the Australian Group on Antimicrobial Resistance. Commun Dis Intell 2007, 31:398-403.
9. Klevens R.M., Morrison M.A., Nadle J., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
10. Griffiths C., Lamagni T.L., Crowcroft N.S., Duckworth G., Rooney C. Trends in MRSA in England and Wales: analysis of morbidity and mortality data for 1993-2002. Health Stat Q 2004, 21:15-22.
11. Laupland K.B., Ross T., Gregson D.B. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008, 198:336-343.
12. Allard C., Carignan A., Bergevin M., et al. Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991-2005. Clin Microbiol Infect 2008, 14:421-428.
13. Monnet D.L., MacKenzie F.M., Lopez-Lozano J.M., et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004, 10:1432-1441.
14. Borg M.A., Suda D., Scicluna E. Time-series analysis of the impact of bed occupancy rates on the incidence of methicillin-resistant Staphylococcus aureus infection in overcrowded general wards. Infect Control Hosp Epidemiol 2008, 29:496-502.
15. Cosgrove S.E., Qi Y., Kaye K.S., Harbarth S., Karchmer A.W., Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005, 26:166-174.
16. Mylotte J.M., Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000, 31:1170-1174.
17. Benfield T., Espersen F., Frimodt-Moller N., et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 2007, 13:257-263.
18. Lyytikäinen O., Ruotsalainen E., Jarvinen A., Valtonen V., Ruutu P. Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001. Eur J Clin Microbiol Infect Dis 2005, 24:399-404.
19. Klein E., Smith D.L., Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007, 13:1840-1846.
20. Pearson A., Chronias A., Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother 2009, 64(Suppl. 1). i11-i17.
21. Department of Health Surveillance of healthcare associated infections. CMO's Update May 2001, vol. 21. DoH, London.
22. Pearson A.D., Wilson J., Mandalia R., Davies J. Stratified analysis of sources of MRSA bacteraemia to inform intervention strategy in the English National Health Service. Proceedings of the 47th Annual Meeting of the Infectious Diseases Society of America October 2009, vol. 29. Philadelphia; 2009.